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SOME IMMUNOLOGIC PHENOMENA IN TREATMENT OF AND
PATCH TESTING FOR RAGWEED OIL DERMATITIS*
A. A. FISHER, M.D.
I THE RELATION OF PATCH TEST REACTIONS TO THE CLINICAL COURSE IN RAGWEED
DERMATITIS TREATED BY THE ORAL METHOD
Prophylaxis and treatment of contact eczematous dermatitis by specific
hyposensitiaztion is still regarded with skepticism. However, there is evidence
that contact dermatitis due to oil oleoresins may possibly afford opportunity for
specific hyposensitization by administration of the causative allergen.
Blumenthal and Jaffe (1) found desensitization successful in contact dermatitis
only when the causative allergen was a plant oil. Shelmire (2) and others have
also published favorable results with specific desensitization to plant oils. How-
ever, Brunsting and Williams (3) reported unfavorably on the value of desensi-
tization, particularly in ragweed oil dermatitis.
Plant oil hyposensitization has been attempted by hypodermic injections,
external applications and by oral administration of the specific alergen. Sulz-
berger and Wise (4) described a case of eczematous dermatitis due to ragweed
in which, after a number of intracutaneous injections of ragweed extract, the
patient's skin no longer gave a positive reaction to ragweed allergen and the
dermatitis improved.
Pascher and Sulzberger (5) mentioned a case in which treatment was attempted
by intracutaneous injections of diluted oil of ragweed. It was noted that the
initial dose provoked a flare-up at sites where positive patch reactions to ragweed
oil had been obtained five months previously.
Thomson (6), in a review of the literature on immunization by the oral route
states that as far as poison ivy is concerned, "It is however probably safe to say
that relief can be obtained by this method in a fair proportion of cases and that,
in general, the specific oleoresin is better given by mouth than by the parenteral
route."
As far as ragweed oil dermatitis is concerned, Sheldon and Blumenthal (7)
concluded that actual desensitization can be accomplished in ragweed oil
dermatitis by oral administration of the specific oil, and by repeated quantitative
patch testing observed a reduction in the quantitative patch reaction in 2 cases.
Shelmire (8) observed patients in whom clinical improvement by the oral de-
sensitization method was accompanied by a reduction in the patch test reaction
to ragweed oil. This author points out, on the other hand, that some individuals
who experience clinical improvement show very little reduction in patch test
reactivity. Shelmire also observed patients who had taken the oleoresin orally
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every year for several years, then have skipped a year. When they failed to take
the oleoresin there was a recurrence of the ragweed dermatitis.
The possibility of spontaneous cure in ragweed oil sensitivity with a spon-
taneous reduction in the patch test reaction was considered. Since we had not
observed such a phenomenon, we inquired of Dr. B. Shelmire whether or not he
had ever encountered spontaneous cures. Dr. Shelmire wrote to say he likewise
had never seen spontaneous cure in ragweed oil sensitivity.
TABLE 1
Relation of patch test to clinical condition in patients receiving the oral method of ragweed
oil pro phylaxis
PATIENT DURATION PATCD TEST CLINICAL APPEARANCE IMPROVEMENT
6DCS per cent
P. B.* 16 1946 3+
1947 3+
1948 2+
1949 neg.
1950 2+
severe
moderate
mild
clear
moderate
25
50
100
25
A. W. 12 1946 3-f-
1947 3+
1948 2+
1949 1+
1950 neg.
severe
moderate
mild
mild
Clear
30
70
90
100
D. V. 7 1946 3+
1947 3+
1948 3+
1949 2+
1950 1-f-
severe
severe
moderate
moderate
mild
10
30
60
80
B. C. 5 1946 3+
1947 2+
1948 1+
1949 neg.
1950 neg.
Revere
moderate
mild
mild
mild
60
90
90
90
* Patient No. 1 lapsed from treatment in 1950. Note clinical recurrence and return of
patch test to positivity.
neg. = no reaction; 1+ = erythema; 2+ = erythema and edema; 3+ = erythema, edema
and vesiculation.
I have observed the phenomenon of improvement in the ragweed oil dermatitis
together with a decrease of the patch reaction in patients who were given oral
ragweed oleoresin prophylactically according to Shelmire's (2) method.
Table 1 shows four patients who have had severe ragweed dermatitis for 5
years or more prior to institution of treatment. Each year the dermatitis had
become progressively worse. All showed strongly positive patch test reactions
before treatment was started and all have been observed since 1946.
It was noted that as the patients improved clinically the strongly positive
patch test reactions became progressively weaker. In two of the four cases the
reactions became negative. Lapse from treatment in Case 1, resulted in a
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clinical relapse and recurrence of patch test reactivity. Fourteen additional
patients observed for a shorter period seemed to be foilowing a similar pattern.
Method of oral desensitization to ragweed dermatitis
Detailed Instruction8 Given To The Patient
The treatment of contact allergy to ragweed consists in the daily digestion of small
amounts of the oil* from these plants over a period of several months or even years. Several
rules must be rigidly followed:
1. Treatment should be started when you are free of the skin eruption.
If you have the skin rash all year round, start the treatment outside of the ragweed
season, either after the first frost or as early in the summer as possible.
2. Ingest gradually increasing amounts of the oil daily.
3. Decrease the number of ingested drops or stop treatment entirely for a few days if
there is a return of the skin rash.
4. Ingest the entire three bottles of oil, which is the minimum amount that will reduce
your sensitivity.
The treatment set consists of three bottles of the specific oleoresin diluted in
corn oil and a supply of No. 1 size gelatin capsules. It contains one ounce each
of the 1:100, the 1:50 and the 1:25 dilution. The fractional ingestion of these
three bottles of oil will furnish the required amount of the pure specific oleoresin
necessary to reduce the cutaneous sensitivity of the individual.
The patient is advised to ingest as an initial dose one drop of the 1:100 dilution
of the oleoresin in a gelatin capsule. Persons should be warned to avoid con-
taminating the fingers with the oil while filling the capsules from the dropper.
Capsules are filled at the time of ingestion and are best tolerated immediately
following the morning or evening meal. An initial dose of one drop of the 1:100
dilution is taken daily for one week. Two drops are ingested daily during the
second week. If no symptoms of intolerance arise during these two weeks, pa-
tients are instructed to increase the number of daily drops as rapidly as their
tolerance permits. Some patients can increase the dosage by two or three or even
more drops weekly. Some patients work up their tolerance to the point that they
can ingest a full capsule (12 drops) or more daily within a month after beginning
treatment. The longer the patient takes the drops, the more rapidly the dosage
can be increased.
After the one-ounce bottle of the 1:100 dilution has been ingested, the patient
then begins the 1:50 dilution starting with approximately half the maximum
number of drops which he was ingesting when the bottle of the 1:100 dilution
was exhausted. If he were taking forty or fifty drops of the 1:100 dilution as a
daily dose, he should start taking twenty to twenty-five drops of the 1:50 dilu-
tion. He should then increase the daily number of drops of this concentration as
rapidly as his or her tolerance permits. Usually within a few weeks after beginning
treatment a patient can judge his own tolerance and can determine about how
rapidly to increase the drops. Dosage depends on pruritus au and skin eruptions.
* The material used was obtained from the Graham Laboratories, Willow Lane 7, Dallas
6, Texas and consists of ragweed oleoresin diluted in corn oil.
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After completion of the 1:50 dilution, the 1:25 concentration is started, again
beginning with half the maximum daily dosage of the previous dilution and in-
creasing the dosage as tolerance permits.
If the total three ounces of oil is taken by increasing the daily dosage by one
drop weekly it usually requires eight months or more to take the required amount
of oil. By increasing the dosage as rapidly as tolerance permits, the patient of
average sensitivity can often ingest the required amount of oil in approximately
two months. A maintenance dose of one capsule (12 drops) of the 1:25 dilution of
the oleoresin should be taken two or three times weekly, for an indefinite period.
Pruritus ani is the most annoying treatment complication. It occurs chiefly
during the early weeks or oral therapy. However, anal pruritus often disappears
even though the dosage is increased. This annoying symptom may be minimized
by thorough cleansing with soap and water after each bowel movement, as this
itching is caused by contact of the perianal skin with the unabsorbed portion of
the specific oil.
[Jrticaria and other skin eruptions are rarely observed if the dosage is not
increased too rapidly. These eruptions are never serious and usually disappear
within a few days after temporary cessation of oral treatment. If such symptoms
occur the patient should be advised to stop treatment until the skin is free of
eruption and then begin treatment at the same or slightly reduced number of
daily drops. Toxic manifestations of this type rarely recur since most patients
develop a tolerance for the oil.
Individuals who start oral therapy late in the season and whose sensitivity
is not sufficiently reduced from oral treatment may develop a dermatitis from
exposure to the specific allergenic plant (Ragweed). In most instances the derma-
titis is decidedly less than previous to oral therapy. Warn patients to avoid ex-
posure to the plant until after completion of oral treatment. If such an eruption
from direct or indirect contact with the plant does occur, oral treatment should
be temporarily stopped. Ingestion of the oil during an actual attack of dermatitis
often exaggerates the eruption.
It is not known at present if reduced sensitivity to ragweed dermatitis and
other plants is permanent. At the present it is advisable to continue to take the
maintenance dose of one capsule (12 drops) of the 1:25 dilution of the oleoresin
for an indefinite period. If the ingestion of the oleoresin is discontinued, the
sensitivity may return.
Method of patch testing with ragweed oleoresin
The classic closed patch test was employed. A - inch linen square was saturated
with the testing material and placed on the skin of the back and covered with an
"Elastopatch" (Duke Laboratories). Readings were made after 48 hours.
The testing material consisted of oleoresin diluted in 10 parts of acetone. This
material was obtained from the Graham Laboratories (Dallas, Texas).
The material was used on 100 controls (patients with unrelated dermatoses)
and was not found to be either a primary irritant or a common sensitizer. Each
patient treated with ragweed oral oleoresin was patch tested every 6 or 8 weeks
for the first 6 months. Thereafter, patients were patch tested every 3 months.
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All the patients in this series are continuing their treatment except patient
No. 1, who lapsed from treatment in 1950. Six months after he stopped taking
the oral therapy his previously negative patch test again became positive. This
patient has not returned for further testing.
II SENSITIZATION TO COLORING MATTER IN RAGWEED OIL PATCH TESTING MATERIAL
The ragweed oleoresin patch testing material was obtained from the Graham
Laboratories (9) who have informed us that coloring matter is added to the
testing extracts to delineate the patch sites. Many plants do not have sufficient
chlorophyll content to make distinct, visible sites at the point of application.
For those who use the open method of testing a colored extract minimizes possi-
bility of error in application.
The coloring material contains a mixture of two dyes in acetone which imparts
green color of chlorophyll. One dye is F D & C Yellow 3 an azo dye, the other
is D & C Green 6 an anthraquinone dye. F D & C Yellow 3 is 1-Phenylazo-
2-Naphthylamine and D & C Green 6 is 1, 4-Bis-(P-toluino) anthraquinone.
Howell (10) and Jaffe (11) have reported cases of sensitization to coloring
matter in testing material but did not determine which dye was the sensitizer.
As a rule in performing patch tests with the oleoresin testing material we
tested the patient to 12 different plants. In 3 patients we obtained strongly posi-
tive reactions to all 12 tests, making it likely that there was some common in-
gredient in the testing material that was the offender. Since none of these patients
reacted to the acetone, it appeared likely that the added coloring material was
the cause of the reaction.
We then tested these three patients with a "control" solution which contained
the dyes dissolved in acetone without any oleoresins. All 3 patients reacted to
this "control" solution.
Thereupon we tested these patients with each of the dyes individually using
a 2% concentration in petrolatum. In each case it was the F D & C Yellow 3
which was the offender. None of the patients reacted to the D & C Green ,6.
Eighteen patients with unrelated dermatoses, but known to react to 2% para-
phenylenediamine in petrolatum, were tested with each of the dyes. Figure 2
shows that twelve of the eighteen patients who reacted to paraphenylenediamine
also reacted to the F D & C Yellow 3. None of the paraphenylenediamine
reactors showed a positive reaction to the green dye.
These observations are in accord with the findings of Baer, Leider & Mayer
(12). They studied 21 patients who were sensitive to paraphenylenediamine.
Patch tests with F D & C Yellow 3 in these cases revealed that sixteen of the
paraphenylenediamine reactors were also sensitive to F D & C Yellow 3.
We also tested 100 consecutive patients who were not paraphenylenediamine
reactors with F D & C Yellow 3 and D & C Green 6. In this series 3 patients
were found to react to the yellow dye and none to the green dye. In other words,
not one patient of the 118 tested showed any reaction to the D & C Green 6.
On the other hand twelve of eighteen paraphenylenediamine reactors proved
sensitive to F D & C Yellow 3, and three of the 100 non-paraphenylenediamine
reactors were sensitive to F D & C Yellow 3 on patch testing.
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Because of these findings, we have requested and obtained oleoresin testing
material without any added coloring matter. Furthermore, coloring matter
serves no purpose in the classic patch method. Furthermore, this appears to be
the method of choice.
All the patch testing was done by the closed patch method and readings were
made after 48 hours.
III ASSOCIATED SENSITIZATIONS IN RAGWEED DERMATITIS
Brunsting and Anderson (13) found that ragweed sensitivity is frequently
accompanied by sensitization to pyrethrum, turpentine, burweed and marsh
elder. Jordan et al (14), in addition, found that sensitization to feverfew, bitter-
TABLE 2
Patch test re8ults showing relation of FD&C yellow 3 and D&C green %6
to paraphenylenediamine
CLINIC NO. YOReYELLOW 3
D&C
GREEN 56
M22446 3+ 2+ neg.
M22613 2+ 2+ neg.
M10555 3+ 2+ neg.
M22911 2+ 2+ neg.
M23566 3+ 2+ neg.
M23541 3+ 2+ neg.
F46174 3+ 3+ neg.
M22873 2+ 3+ neg.
M21417 3+ 2+ neg.
M22952 2+ 2+ neg.
M22706 3+ 2+ neg.
M22256 2+ 2+ neg.
M22778 2+ neg. neg.
M23433 2+ neg. neg.
M23544 3+ neg. neg.
M22758 3+ neg. neg.
M22684 3+ neg. neg.
M11506 2+ neg. neg.
neg. = no reaction; 1+ = erythema; 2+ = erythema and edema; 3+ = erythema,
edema and vesiculation.
weed and in a few instances flax and its products such as linseed oil accompanied
sensitization to ragweed oleoresin. These authors point out that it is thus possible
for ragweed dermatitis to persist as a result of exposure to these plants or their
derivatives such as paints or insecticides.
Brunsting and Anderson, in a series of eighteen cases of ragweed dermatitis,
found 5 cases sensitive to pyrethrum, 3 to turpentine, 2 to cockelbur and none to
linseed oil. They apparently did not test their patients to chrysanthemum.
Jordan et al, make no mention of testing ragweed cases in their series
to pyrethrum.
Each one of our eighteen proven cases of ragweed dermatitis was tested in
addition to ragweed oleoresin, to cockelbur, sheep sorrell, hickory, buck horn,
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Kentucky blue grass, red top, poison ivy, orchard grass, timothy, pyrethrum,
oak, chrysanthemum and turpentine.
Table 3 shows that every one of the ragweed cases reacted to pyrethrum, 4
reacted to chrysanthemum and 6 to turpentine. There were no reactions to
TABLE 3
Patch test reaction in 18 cases of ragweed dermatitis
RAGWRSD PYRETERUM POISON IVY TURPENTINE CHRYSANTEE- COCKLEBUR
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
12.
14.
15.
16.
17.
18.
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
3+
2+
neg.
neg.
2+
neg.
neg.
3+
neg.
2+
neg.
neg.
1+
neg.
3+
neg.
neg.
2+
1+
neg.
2+
neg.
neg.
2+
2+
neg.
neg.
3+
neg.
neg.
2+
neg.
2+
neg.
neg.
neg.
neg.
neg.
2+
neg.
1+
neg.
neg.
neg.
neg.
1+
neg.
neg.
1+
neg.
neg.
neg.
neg.
neg.
neg.
2+
neg.
neg.
3+
neg.
neg.
2+
neg.
neg.
neg.
nag.
neg.
neg.
neg.
neg.
2+
neg.
neg.
neg. = no reaction; 1+ = erythema; 2+ = erythema and edema; 3+ = erythema,
edema and vesiculation.
TABLE 4
Pyrethrum dermatitis patch test reaction to ragweed oleoresin
CASE PYRETERUM RAGWEED
1.
2.
3.
4.
5.
6.
7.
8.
3+
3+
3+
3+
3+
3+
3+
3+
1+
neg.
3+
neg.
neg.
neg.
1+
neg.
neg. = no reaction; 1+ = erythema; 2+ = erythema and edema; 3± = erythema,
edema and vesiculation.
sheep sorrell, hickory, buck horn, Kentucky blue grass, red top, orchard grass,
timothy or oak.
We also had 8 cases of pyrethrum dermatitis in which there was no suspicion
clinically of ragweed dermatitis. Table 4 shows that in only 3 of these pyrethrum
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hypersensitive cases was there a reaction to ragweed oleoresin and in only one
case was it strongly positive. Thus while eighteen patients with ragweed derma-
titis reacted strongly to pyrethrum, only three of eight pyrethrum sensitive pa-
tients reacted to ragweed oleoresin.
No reactions to ragweed oleoresin were elicited in six cases of turpentine
dermatitis of the hands.
One weakly positive reaction to ragweed oleoresin was observed in two cases
of chrysanthemum dermatitis.
We have added pyrethrum to the orally administered prophylactic oleoresin
material in our most recent cases of ragweed dermatitis. It is too early to state
whether or not the pyrethrum patch test will elicit the same reaction pattern as
the ragweed oleoresin.
SUMMARY
1. Eighteen cases of ragweed dermatitis of long duration have been treated
by the oral hyposensitization method. Four patients have been followed for five
years. It was noted that clinical improvement was accompanied by reduction in
the reaction of the patch test in these four cases. Omission of treatment in one
case for one year was followed by an immunologic relapse as indicated by the
altered reaction to patch testing. Fourteen cases treated for a shorter period
seem to be following a similar pattern.
2. We advocate oleoresin testing material without added coloring material
since false positive reactions may be obtained when the certified dye, yellow
F D & C , 3 is added. This dye is a eczematogenous allergen and produces
cross reactions with paraphenylenediamine. Green D & C 6, an ingredient of
the coloring material, apparently is not a sensitizer. One hundred eighteen pa-
tients, including eighteen paraphenylenediamine reactors, failed to react to
GreenD&C 6.
3. All of the eighteen cases of ragweed dermatitis in this series reacted strongly
to patch tests with pyrethrum. However only 3 of 8 patients with pyrethrum
dermatitis reacted to patch tests with ragweed oleoresin. Eight of the eighteen
ragweed-oil sensitive patients also reacted to poison ivy, 6 reacted to turpentine,
4 to cocklebur and to chrysanthemum.
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DR. LIvING00D, Galveston: I appreciate this paper of Dr. Fisher's because it is
most important to have data on the course of these patients who receive oral
weed extracts in an attempt to cause hyposensitization to the causative allergen.
I have been using these oral extracts for the past five years, and it has been my
impression that this procedure has resulted in significant improvement for
those patients who received an adequate amount of the material.
It would be well for Dr. Fisher to outline the exact details regarding the ad-
ministration of the extract in his patients, including the amount of the extract
which was given during each period of twelve months.
Also, I would like to add that I agree that it is preferable to use closed patch
tests rather than open patch tests in determining the sensitivity of persons with
weed dermatitis. As I understand it, the distributor of these weed extracts recom-
mends the open patch test procedure.
DR. ROTHMAN, CHICAGO: Does the sensitivity to ragweed persist for lifetime?
Isn't it feasible that there are spontaneous fluctuations in degree of sensitivity
in such a long time period as three years?
DR. FIsHER: In answer to Dr. Livingood's question about the maintenance
dose. After the patients have finished their third bottle {the treatment outfit
comes in a set of three bottles—dilutions 1 to 25, 1 to 50 and 1 to 100. We start
off with dilution 1 to 100. When they finish that bottle they go to 1 to 50, then
1 to 25.]. Once they finish their bottle of 1 to 25 dilution, we keep them on a
maintenance dose of 12 drops of the 1 to 25 dilution twice a week indefinitely
throughout the year.
The question that Dr. Rothman brought up puzzled us a great deal. We had
never seen a patient with ragweed dermatitis who cleared spontaneously. I
wrote a letter to Dr. Shelmire who has had a great deal of experience and he
also wrote that he never heard or saw a patient who had cleared spontaneously
from ragweed dermatitis. These patients apparently have their ragweed derma-
titis as long as they are untreated or as long as they live in the same environment.
